Your Article Summary
See Latest ArticlesBreakdown in epithelial barrier function in patients with asthma: Identification of novel therapeutic approaches
Journal of Allergy and Clinical Immunology, 06/29/09
Swindle EJ et al. - The bronchial epithelium is pivotally involved in the provision of chemical, physical, and immunologic barriers to the inhaled environment. These barriers serve to maintain normal homeostasis, but when compromised, the immunologic barrier becomes activated to protect the internal milieu of the lung. The authors discuss what is currently understood about abnormalities in these barrier functions in patients with asthma and consider novel therapeutic opportunities that target this key structure.
Related Articles
Clinical importance of identifying immunoglobulin E-mediated disease in patients with Asthma
Clinical Cornerstone, 10/01/09
Relevance Score: 96%
Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma
Osteoporosis International, 10/13/09
Relevance Score: 95%
The Saudi Initiative for asthma
Annals of Thoracic Medicine, 10/13/09
Relevance Score: 95%
Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study
Journal of Allergy and Clinical Immunology, 10/09/09
Relevance Score: 95%
Identification of Asthma Phenotypes using Cluster Analysis in the Severe Asthma Research Program
American Journal of Respiratory and Critical Care Medicine, 11/09/09
Relevance Score: 94%
Today in Cardiovascular/Pulm...keeping you current
Receive free subspecialty "5-minute updates" via email
Lower cortisol levels in children with asthma exposed to recurrent maternal distress from birth
Journal of Allergy and Clinical Immunology, 12/10/09
Morphine Disrupts the IL-23/IL-17 Mediated Pulmonary Mucosal Host Defense Against S. pneumoniae Infection
Infection and Immunity, 12/10/09
Dual-Function Antibodies to Yersinia pestis LcrV Required for Pulmonary Clearance of Plague
Clinical and Vaccine Immunology, 12/10/09